Cecilia Pandini

Cecilia Pandini

Auto-generated profile, based on publicly available information

Cecilia Pandini

Genomic and Post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SGStella Gagliardi
Stella Gagliardi
SZSusanna Zucca
Susanna Zucca
CPCecilia Pandini
Cecilia Pandini
LDLuca Diamanti
Luca Diamanti
MBMatteo Bordoni
Matteo Bordoni
CCCristina Cereda
Cristina Cereda
Alteration in RNA metabolism, concerning both coding and long non-coding RNAs (lncRNAs), may play an important role in Amyotrophic Lateral Sclerosis (ALS) pathogenesis. In this work, we performed a whole transcriptome RNA-seq analysis to investigate the regulation of non-coding and coding RNAs in Sporadic ALS patients (SALS), mutated ALS patients (FUS, TARDBP and SOD1) and matched controls in Peripheral Blood Mononuclear Cells (PBMC). Selected transcripts were validated in spinal cord tissues. A total of 293 differentially expressed (DE) lncRNAs was found in SALS patients, whereas a limited amount of lncRNAs was deregulated in mutated patients. A total of 87 mRNAs was differentially expressed in SALS patients; affected genes showed an association with transcription regulation, immunity and apoptosis pathways. Taken together our data highlighted the importance of extending the knowledge on transcriptomic molecular alterations and on the significance of regulatory lncRNAs classes in the understanding of ALS disease. Our data brought the light on the importance of lncRNAs and mRNAs regulation in central and peripheral systems, offering starting points for new investigations about pathogenic mechanism involved in ALS disease.

1 October 2021 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
SGStella Gagliardi
Stella Gagliardi
EPEmanuele Tino Poloni
Emanuele Tino Poloni
CPCecilia Pandini
Cecilia Pandini
MGMaria Garofalo
Maria Garofalo
FDFrancesca Dragoni
Francesca Dragoni
CCCristina Cereda
Cristina Cereda
SARS-Cov-2 infection is frequently associated with Nervous System manifestations. However, it is not clear how SARS-CoV-2 can cause neurological dysfunctions and which molecular processes are affected in the brain. In this work, we examined the frontal cortex tissue of patients who died of COVID-19 for the presence of SARS-CoV-2, comparing qRT-PCR with ddPCR. We also investigated the transcriptomic profile of frontal cortex from COVID-19 patients and matched controls by RNA-seq analysis to characterize the transcriptional signature.

1 December 2018 in Non-coding RNA Research
Verified
Journal Article
Open access
SGStella Gagliardi
Stella Gagliardi
CPCecilia Pandini
Cecilia Pandini
MGMaria Garofalo
Maria Garofalo
MBMatteo Bordoni
Matteo Bordoni
OPOrietta Pansarasa
Orietta Pansarasa
CCCristina Cereda
Cristina Cereda
Alterations in RNA metabolism play an important role in Amyotrophic Lateral Sclerosis (ALS) pathogenesis. The literature has described, so far, a small number of long non coding RNAs (lncRNAs) associated to ALS demonstrating that how there is still much to do to identify and understand their role in ALS. This class of RNAs may offer numerous starting points for new investigations about pathogenic mechanism involved in ALS disease. In this review, we have collected all the presented data about lncRNAs and ALS to offer an overview about this class of non-coding RNAs and their possible role in ALS disease.

5 February 2019 in Scientific Data
Verified
Journal Article
Open access
PDF file
SZSusanna Zucca
Susanna Zucca
SGStella Gagliardi
Stella Gagliardi
CPCecilia Pandini
Cecilia Pandini
LDLuca Diamanti
Luca Diamanti
MBMatteo Bordoni
Matteo Bordoni
CCCristina Cereda
Cristina Cereda
Coding and long non-coding RNA (lncRNA) metabolism is now revealing its crucial role in Amyotrophic Lateral Sclerosis (ALS) pathogenesis. In this work, we present a dataset obtained via Illumina RNA-seq analysis on Peripheral Blood Mononuclear Cells (PBMCs) from sporadic and mutated ALS patients (mutations in FUS, TARDBP, SOD1 and VCP genes) and healthy controls. This dataset allows the whole-transcriptome characterization of PBMCs content, both in terms of coding and non-coding RNAs, in order to compare the disease state to the healthy controls, both for sporadic patients and for mutated patients. Our dataset is a starting point for the omni-comprehensive analysis of coding and lncRNAs, from an easy to withdraw, manage and store tissue that shows to be a suitable model for RNA profiling in ALS.

29 September 2021 in Data in Brief
Verified
Journal Article
Open access
MGMaria Garofalo
Maria Garofalo
SGStella Gagliardi
Stella Gagliardi
SZSusanna Zucca
Susanna Zucca
CPCecilia Pandini
Cecilia Pandini
FDFrancesca Dragoni
Francesca Dragoni
CCCristina Cereda
Cristina Cereda
Since the association of SARS-Cov-2 infection with Nervous System (NS) manifestations, we performed RNA-sequencing analysis in Frontal Cortex of COVID-19 positive or negative individuals and affected or not by Dementia individuals. We examined gene expression differences in individuals with COVID-19 and Dementia compared to Dementia only patients by collecting transcript counts in each sample and performing Differential Expression analysis. We found eleven genes satisfying our significance criteria, all of them being protein coding genes.

15 April 2025 in Data in Brief
Verified
Journal Article
Open access
GPGiulia Pagani
Giulia Pagani
CPCecilia Pandini
Cecilia Pandini
MTMartina Tassinari
Martina Tassinari
PGPaolo Gandellini
Paolo Gandellini
The recent discovery of antisense RNAs (asRNAs) as key regulators of biological processes has highlighted the need to challenge their mechanism(s) of action using complementary approaches. Indeed, asRNAs can act in cis on their sense gene or in trans on distally located targets, by exploiting either transcription- or RNA-dependent mechanisms. Here we present a comparative transcriptome profiling of cancer cells knocked-down for the asRNA NFYC-AS1 with two different approaches: i) Gapmer Antisense Oligonucleotides to assess RNA-dependent mechanisms, and ii) CRISPR/Cas9 deletion of the transcription start site to study transcription-dependent mechanisms. We describe in detail the strategies used to silence the asRNA and evaluate the consequences at the transcriptome level by RNA-sequencing. Moreover, we outline the analyses conducted to correctly manage the variability across replicates and the off-target effects of either method. The integration of the obtained datasets revealed commonalities and divergencies of the two approaches, which was fundamental for dissecting NFYC-AS1 function. The information reported here can help researchers to reuse the data described in the datasets. Finally, the comparative workflow can be potentially applied to the functional study of any asRNA of interest.